Selvita to Acquire Fidelta from Galapagos for ~$37M

Shots:

• Selvita to acquire 100% of the outstanding shares in Fidelta for $37.08M + customary adjustments for net cash & working capital
• The acquisition will expand Selvita’s integrated drug discovery services offering with the addition of Fidelta
• Fidelta will be fully consolidated under Selvita Group & will continue to operate under the Fidelta name. Fidelta will continue to perform drug discovery services for Galapagos for the next five years

Click here ­to­ read full press release/ article | Ref: GlobeNewswire | Image: Fidelta